BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24507426)

  • 1. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
    Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
    Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography.
    Alizadeh LS; Koch V; Vogl TJ; Yel I; Gruenewald L; Albrecht MH; Herrmann E; von Knebel-Doeberitz PL; Booz C
    Acad Radiol; 2022 Jul; 29(7):e109-e118. PubMed ID: 34598867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
    Letzen BS; Malpani R; Miszczuk M; de Ruiter QMB; Petty CW; Rexha I; Nezami N; Laage-Gaupp F; Lin M; Schlachter TR; Chapiro J
    Clin Imaging; 2021 Oct; 78():194-200. PubMed ID: 34022765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.
    Kim EH; Oh JS; Chun HJ; Choi BG; Lee HG
    Diagn Interv Radiol; 2018 Sep; 24(5):262-267. PubMed ID: 30211679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    Cho Y; Lee S; Park SJ
    PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure.
    Lucatelli P; De Rubeis G; Ginnani Corradini L; Basilico F; Di Martino M; Lai Q; Ginanni Corradini S; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
    Eur J Radiol; 2020 Mar; 124():108806. PubMed ID: 31945673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
    Lucatelli P; De Rubeis G; Basilico F; Ginanni Corradini L; Corona M; Bezzi M; Catalano C
    Radiol Med; 2019 Dec; 124(12):1212-1219. PubMed ID: 31473930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.
    Dioguardi Burgio M; Sartoris R; Libotean C; Zappa M; Sibert A; Vilgrain V; Ronot M
    Cancer Imaging; 2019 Nov; 19(1):75. PubMed ID: 31730491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE.
    Hu B; Zhong BY; Zhang L; Dai C; Li W; Shen J; Huang P; Zhang S; Li Z; Ni CF
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1460-1467. PubMed ID: 32500251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response.
    O'Donohoe RL; Kavanagh RG; Cahalane AM; Houlihan DD; McCann JW; Ryan ER
    Eur Radiol Exp; 2019 May; 3(1):21. PubMed ID: 31144237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor.
    Yue J; Sun X; Cai J; Yin FF; Yin Y; Zhu J; Lu J; Liu T; Yu J; Shi X; Song J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):834-41. PubMed ID: 21377291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.